Palantir: sell signal fades as the sector gathers momentum
Sell signal at week 6 on Palantir, with strength down to 3 out of 100 and the confirmation week closing bullish. Our model flags trading as not recommended: conditions do not support new short positions.
Phio Pharmaceuticals: sell signal in week 2, strength at its lowest
Phio Pharmaceuticals shows a sell signal in week 2 with a strength of just 2 out of 100, at the bottom of the ranking. Our model flags elevated risk: trading not recommended for new entries.
Procter & Gamble: long-running sell signal, but strength is nearly spent
Sell signal at week 11 on Procter & Gamble: strength at 25 out of 100 and fading, trading not recommended per our model. The weekly confirmation closes bearish, but the technical picture lacks conviction.
Pfizer at week 2 of observation: weak signal, trading not recommended
Pfizer is at week 2 of observation of a sell signal. Signal strength stands at 4 out of 100 and the technical picture does not confirm the direction: our model classifies trading as not recommended.
PepsiCo: sell signal unconfirmed, market in wait-and-see mode
PepsiCo carries a sell signal active for 11 weeks, yet 3 observation weeks closed sideways with no confirmation. Strength 42/100, trading not recommended per our model.
PG&E Corporation: fourth week of a sell signal, strength at lows
PG&E Corporation carries a sell signal into its 4th week with a strength of 2 out of 100, near the bottom of the US short ranking. Our model flags elevated risk: trading not recommended.